Endothelium-dependent vasodilation in response to Pseudomonas aeruginosa lipopolysaccharide: An in vitro study on canine arteries

Brazilian Journal of Medical and Biological Research

Volumn 31, Issue 10, 1998, Pages 1329-1334

  Evora, P R B ^a,b   Ekin, S ^a   Pearson, P J ^a   Schaff, H V ^a  

^a MAYO CLINIC   (United States)

^b NONE   (Brazil)

Author keywords

EDRF; Endothelium derived relaxing factor; Hypotension; Nitric oxide; Sepsis

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; ENDOTHELIUM DERIVED RELAXING FACTOR; NITRIC OXIDE;

ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DOG; GRAM NEGATIVE INFECTION; HYPOTENSION; NONHUMAN; PSEUDOMONAS AERUGINOSA; SEPTICEMIA; VASCULAR ENDOTHELIUM; VASODILATATION;

ANIMALIA; BACTERIA (MICROORGANISMS); CANIS FAMILIARIS; NEGIBACTERIA; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA;

EID: 0031727111     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X1998001000014     Document Type: Article

References (24)

1. Dudley MN (1990). Overview of gram negative sepsis, American Journal of Hospital Pharmacy, 47 (Suppl 3): S3-S6
2. Fairman RP & Glauser FL (1980). Pathophysiologic alterations in endotoxemia. Similarities to an animal model. Archives of Internal Medicine, 140: 788-790.
3. Lechi A, Arosio E, Pancera P, Anesi P, Zannni G, Todeschini G & Cetto G (1984). Pseudomonas septicemia. A review of 60 cases observed in a university hospital. Journal of Hospital Infection, 5: 29-37.
4. Miller PJ & Wenzel RP (1987). Etiologic organisms as independent predictors of death and morbidity associated with bloodstream infections. Journal of Infectious Diseases, 156: 471-477.
5. Parratt JR (1989). Alterations in vascular reactivity in sepsis and endotoxemia. In: Vincent JL (Editor), Update in Intensive Care. Vol X. Springer-Verlag, Berlin, 299-308
6. Nathanson C, Eichenholz PW, Danner RL, Eichacker PQ, Hoffman WD, Kuo GC, Banks SM, MacVittie TJ & Parrillo JE (1989). Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile in human septic shock. Journal of Experimental Medicine, 169: 823-832.
7. Kopolovic R, Thrailkill KM, Martin DT, Carey LC & Cloutier CT (1986). A critical comparison of the hematologic, cardiovascular, and pulmonary response to steroids and non-steroidal anti-inflammatory drugs in a model of sepsis and adult respiratory distress syndrome. Surgery, 100: 679-690.
8. Atik M, Liu PV, Hanson BA, Amini S & Rosenberg CF (1968). Pseudomonas endotoxin shock. A preliminary report of studies in the dog. Journal of the American Medical Association, 205: 134-140.
9. Furchgott RF & Zawadzki JV (1980). The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature, 288: 373-376
10. Ignarro LJ. Buga GM, Wood K, Byrns RE & Chaudhuri G (1987). Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proceedings of the National Academy of Sciences, USA, 84: 9265-9269.
11. Palmer RMJ, Ferrige AG & Moncada S (1987). Nitric oxide accounts for the biological activity of endothelium-derived relaxing factor. Nature. 327: 524-526.
12. Ignarro LJ, Lippton H, Edwards JC, Baricos WH, Hyman AL, Kadowitz PJ & Gruetter CA (1981). Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside, and nitric oxide: Evidence for involvement of S-nitrosothiols as active intermediates. Journal of Pharmacology and Experimental Therapeutics, 218: 739-749.
13. Pearson PJ, Schaff HV & Vanhoutte PM (1990). Acute impairment of endothelium-dependent relaxations to aggregating platelets following reperfusion injury in canine coronary arteries. Circulation Research, 67: 385-393.
14. Rees DD, Palmer RMJ, Hodson HF & Moncada S (1989). A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation. British Journal of Pharmacology, 96 418-424.
15. Palmer RMJ, Ashton DS & Moncada S (1988). Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature, 333 664-666.
16. Förstermann U, Closs El, Pollock JS, Nakane M, Schwarz P, Gath I & Kleinert H (1994). Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions. Hypertension, 23 (Part 2): 1121-1131.
17. Knowles RG, Salter M, Brooks SL & Moncada S (1990). Anti-inflammatory glucocorticoids inhibit the induction by endotoxin of nitric oxide synthesis in lung, liver. and aorta of the rat. Biochemical and Biophysical Research Communications, 172: 1042-1048.
18. Fleming I, Ju uo-Schaeffer G, Gray GA, Parrat JR & Stoclet JE (1991). Evidence that an L-arginne/nitric oxide-dependent elevation of tissue cyclic GMP content is involved in depression of vascular reactivity by endotoxin. British Journal of Pharmacology, 103: 1047-1052.
19. Fleming I, Gray GA, Schott C & Stoclet J (1991). Inducible but not constitutive production of nitric oxide by vascular smooth muscle cells. European Journal of Pharmacology, 200: 375-376.
20. Radomski MW, Palmer RMJ & Moncada S (1990). Glucocorticoids inhibit the expression of an inducible, but not constitutive, nitric oxide synthase in vascular endothelial cells. Proceedings of the National Academy of Sciences, USA, 87: 10043-10047
21. Scott JA, Machoun M & McCormack DG (1996) Inducible nitric oxide synthase and vascular reactivity in rat thoracic aorta: effect of aminoguanidine. Journal of Applied Physiology, 80: 271-277.
22. Liaudet L, Feihl F, Rosselet A, Markert M, Hurni JM & Perret C (1996). Beneficial effects of L-canavanine, a selective inhibitor of inducible nitric oxide synthase, during rodent endotoxaemia. Clinical Science. 90: 369-377.
23. Schwartz D, Mendonca M, Schwartz I, Xia Y, Satrinano J, Wilson CB & Blantz RC (1997). Inhibition of constitutive nitric oxide synthase (NOS) by nitric oxide generated by inducible NOS after lipopolysaccharide administration provokes renal dysfunction in rats. Journal of Clinical Investigation, 100: 439-448.
24. Liu SF, Barnes PJ & Evans TW (1997). Time course and cellular localization of lipopolysaccharide-induced inducible nitric oxide synthase messenger RNA expression in the rat in vivo. Critical Care Medicine, 25: 512-518.